Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-037428
Filing Date
2022-06-16
Accepted
2022-06-16 16:31:11
Documents
1
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4035
  Complete submission text file 0001209191-22-037428.txt   5416
Mailing Address C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address
Lichter Jay (Reporting) CIK: 0001376355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 221021007

Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations